Compound class:
Synthetic organic
Comment: MMV693183 is an optimized preclinical candidate from the pantothenamide class of antimalarial compounds [2].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. de Vries LE, Jansen PAM, Barcelo C, Munro J, Verhoef JMJ, Pasaje CFA, Rubiano K, Striepen J, Bolscher JM, Henderson R et al.. (2021)
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. bioRxiv, Preprint. DOI: 10.1101/2021.05.12.443866 |
2. Schalkwijk J, Hermkens PHH, Dechering KJ, Bonnert RV. (2020)
Pantothenamide analogues. Patent number: WO2020141155A1. Assignee: Medicines for Malaria Venture (MMV). Priority date: 31/12/2018. Publication date: 09/07/2020. |